CAREMARK RX INC 4
4 · CAREMARK RX INC · Filed Mar 26, 2007
Insider Transaction Report
Form 4
GOLDING DAVID W
EVP-Specialty Pharmacy
Transactions
- Disposition to Issuer
Stock Option
2007-03-22−100,000→ 0 totalExercise: $32.03From: 2005-05-10Exp: 2014-05-10→ Common Stock, par value $.001 (100,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−75,000→ 0 totalExercise: $50.84From: 2007-03-01Exp: 2016-03-01→ Common Stock, par value $.001 (75,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−150,000→ 0 totalExercise: $37.92From: 2006-03-01Exp: 2015-03-01→ Common Stock, par value $.001 (150,000 underlying) - Disposition to Issuer
Stock Option
2007-03-22−25,000→ 0 totalExercise: $18.35From: 2003-04-02Exp: 2013-04-02→ Common Stock, par value $.001 (25,000 underlying) - Disposition to Issuer
Common Stock, par value $.001
2007-03-22−976.294→ 0 total
Footnotes (2)
- [F1]Disposed of pursuant to a merger agreement between issuer and CVS Corporation at the rate of 1.67 shares of CVS/Caremark Corporation common stock for each share of issuer stock. All issuer shares held by Reporting Person were disposed.
- [F2]Issuer options are being replaced in the merger with CVS/Caremark Corporation options exercisable for CVS/Caremark Corporation common stock. The number of CVS/Caremark Corporation common shares and the exercise price of the CVS/Caremark Corporation replacement option will be computed using a formula that will result in the Reporting Person receiving an intrinsic value in the CVS/Caremark Corporation replacement option that will be approximately equal to the intrinsic value of the issuer options valued immediately prior to the merger.